Dong-A Pharmaceutical Launches Acne Treatment 'Akrinvitagel'
Formulated with 4% Niacinamide
Dong-A Pharmaceutical announced on September 18 that it has launched 'Akrinvitagel,' an acne treatment containing 4% niacinamide as its main ingredient.
Niacinamide, a form of vitamin B3, is known to regulate sebum secretion and inhibit the production of inflammatory mediators. With 4% niacinamide, Akrinvitagel helps control excessive sebum secretion and manage inflammation.
Akrinvitagel is a new addition to Dong-A Pharmaceutical's acne treatment brand 'Acne.' The Acne brand provides customized treatment solutions tailored to symptoms and causes, reflecting the fact that acne develops from a complex interplay of factors, including sebum secretion, excessive keratinization of the pores, proliferation of acne-causing bacteria, and inflammation.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
A representative from Dong-A Pharmaceutical stated, "We will continue to further segment and strengthen the acne treatment solutions offered by the Acne brand."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.